ArticleRSC advances2020
Development of TsDPEN based imine-containing ligands for the copper-catalysed asymmetric Kinugasa reaction.
Chuanlong Xu, Yuchen Yang, Yue Wu, Feilong He, Huakang He, Ping Deng, Hui Zhou
Abstract read
In one paragraphArticle in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Chuanlong XuChongqing Research Center for Pharmaceutical Engineering, Research Center for Innovative Pharmaceutical and Excipient Analysis Technology, College of Pharmacy, Chongqing Medical University Chongqing 400016 China hzhou@cqmu.edu.cn orangedp@cqmu.edu.cn.
Yuchen YangChongqing Research Center for Pharmaceutical Engineering, Research Center for Innovative Pharmaceutical and Excipient Analysis Technology, College of Pharmacy, Chongqing Medical University Chongqing 400016 China hzhou@cqmu.edu.cn orangedp@cqmu.edu.cn.
Yue WuChongqing Research Center for Pharmaceutical Engineering, Research Center for Innovative Pharmaceutical and Excipient Analysis Technology, College of Pharmacy, Chongqing Medical University Chongqing 400016 China hzhou@cqmu.edu.cn orangedp@cqmu.edu.cn.
Feilong HeChongqing Research Center for Pharmaceutical Engineering, Research Center for Innovative Pharmaceutical and Excipient Analysis Technology, College of Pharmacy, Chongqing Medical University Chongqing 400016 China hzhou@cqmu.edu.cn orangedp@cqmu.edu.cn.ORCID https://orcid.org/0000-0002-5985-3644 Huakang HeChongqing Research Center for Pharmaceutical Engineering, Research Center for Innovative Pharmaceutical and Excipient Analysis Technology, College of Pharmacy, Chongqing Medical University Chongqing 400016 China hzhou@cqmu.edu.cn orangedp@cqmu.edu.cn.
Ping DengChongqing Research Center for Pharmaceutical Engineering, Research Center for Innovative Pharmaceutical and Excipient Analysis Technology, College of Pharmacy, Chongqing Medical University Chongqing 400016 China hzhou@cqmu.edu.cn orangedp@cqmu.edu.cn.
Hui ZhouChongqing Research Center for Pharmaceutical Engineering, Research Center for Innovative Pharmaceutical and Excipient Analysis Technology, College of Pharmacy, Chongqing Medical University Chongqing 400016 China hzhou@cqmu.edu.cn orangedp@cqmu.edu.cn.ORCID https://orcid.org/0000-0001-7018-3277 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Identifiers
PMID35517194
PMCPMC9053751
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390